Coexpression of δ-opioid receptors with μ receptors in GH3 cells changes the functional response to μ agonists from inhibitory to excitatory

Molecular Pharmacology

Volumn 63, Issue 1, 2003, Pages 89-95

  Charles, Andrew C ^a   Mostovskaya, Natalya ^a   Asas, Kathleen ^a   Evans, Christopher J ^a   Dankovich, Megan L ^b   Hales, Tim G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCIUM CHANNEL; CALCIUM ION; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; PERTUSSIS TOXIN; PHOSPHOLIPASE C; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; BIOASSAY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ACTIVITY; CONTROLLED STUDY; ENZYME INHIBITION; LONG TERM CARE; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANALGESICS, OPIOID; ANIMALS; BARIUM; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; ELECTROPHYSIOLOGY; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENZYME INHIBITORS; ESTRENES; PATCH-CLAMP TECHNIQUES; PERTUSSIS TOXIN; PYRROLIDINONES; RATS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SOMATOSTATIN; THAPSIGARGIN; TRANSFECTION;

EID: 0037220638     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.1.89     Document Type: Article

References (35)

1. Abdelhamid EE, Sultana M, Portoghese PS, and Takemori AE (1991) Selective blockage of 5 opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258:299-303.
2. Camps M, Carozzi A, Schnabel P, Scheer A, Parker PJ, and Gierschik P (1992) Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits. Nature (Lond) 360:684-686.
3. Chan JS, Lee JW, Ho MK, and Wong YH (2000) Preactivation permits subsequent stimulation of phospholipase C by Gi-coupled receptors. Mol Pharmacol 57:700-708.
4. 2+ oscillations and have distinct roles in prolactin release in GH3 cells. J Biol Chem 274:7508-7515.
5. 2+ in SH-SY5Y cells. Brain Res 882:256-265.
6. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, and O'Dowd BF (2000) Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135.
7. Gomes I, Jordan BA, Gupta A, Rios C, Trapaidze N, and Devi LA (2001) G protein coupled receptor dimerization: Implications in modulating receptor function. J Mol Med 79:226-242.
8. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, and Devi LA (2000) Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 20:RC110.
9. Jin W, Lee NM, Loh HH, and Thayer SA (1992) Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Mol Pharmacol 42:1083-1089.
10. Jordan BA, Cvejic S, and Devi LA (2000) Opioids and their complicated receptor complexes. Neuropsychopharmacology 23:S5-S18.
11. Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature (Lond) 399:697-700.
12. 5]enkephalin. J Biol Chem 276:37779-37786.
13. Maggio R, Vogel Z, and Wess J (1993) Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc Natl Acad Sci USA 90:3103-3107.
14. 3 cells. Mol Pharmacol 59:774-783.
15. IR channel activation. J Neurophysiol 83:2691-2698.
16. 2+ channels in GH3 cells by cloned μ- and δ-opioid receptors. Mol Pharmacol 50:947-956.
17. 2+ channel and adenylyl cyclase modulation by cloned μ-opioid receptors in GH3 cells. Mol Pharmacol 47:1041-1049.
18. Prather PL, Loh HH, and Law PY (1994a) Interaction of δ-opioid receptors with multiple G proteins: A non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Mol Pharmacol 45:997-1003.
19. 2+ channels in transfected rat pituitary cells. J Pharmacol Exp Ther 295:552-562.
20. Prather PL, Tsai AW, and Law PY (1994b) Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. J Pharmacol Exp Ther 270:177-184.
21. q-coupled receptors is mediated by Gβγ exchange. Proc Natl Acad Sci USA 96:10626-10631.
22. Sanchez-Blazquez P, Garcia-Espana A, and Garzon J (1997) Antisense oligodeoxynucleotides to opioid μ and δ receptors reduced morphine dependence in mice: Role of δ-2 opioid receptors. J Pharmacol Exp Ther 280:1423-1431.
23. Sanchez-Blazquez P and Garzon J (1998) δ Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J Pharmacol Exp Ther 285:820-827.
24. Sanchez-Blazquez P, Gomez-Serranillos P, and Garzon J (2001) Agonists determine the pattern of G-protein activation in μ-opioid receptor-mediated supraspinal analgesia. Brain Res Bull 54:229-235.
25. 2+ from intracellular stores, in undifferentiated NG108-15 cells. J Neurochem 66:1462-1467.
26. Smart D, Smith G, and Lambert DG (1995) Mu-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening. Biochem J 305:577-581.
27. 2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes. Biochem Pharmacol 54:809-818.
28. Traynor JR and Elliott J (1993) Delta-opioid receptor subtypes and cross-talk with mu-receptors. Trends Pharmacol Sci 14:84-86.
29. Von Zastrow M, Keith DE Jr, and Evans CJ (1993) Agonist-induced state of the δ-opioid receptor that discriminates between opioid peptides and opiate alkaloids. Mol Pharmacol 44:166-172.
30. Wang Z, Bilsky EJ, Porreca F, and Sadee W (1994) Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci 54:L339-L350.
31. Williams JT, Christie MJ, and Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
32. Xie W, Samoriski GM, McLaughlin JP, Romoser VA, Smrcka A, Hinkle PM, Bidlack JM, Gross RA, Jiang H, and Wu D (1999) Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids. Proc Natl Acad Sci USA 96:10385-10390.
33. Yeo A, Samways DS, Fowler CE, Gunn-Moore F, and Henderson G (2001) Coincident signalling between the Gi/Go-coupled delta-opioid receptor and the Gq-coupled m3 muscarinic receptor at the level of intracellular free calcium in SH-SY5Y cells. J Neurochem 76:1688-1700.
34. 2+ stores in NG108-15 cells. Mol Pharmacol 56:902-908.
35. Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, Unterwald E, Pasternak GW, and Pintar JE (1999) Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24:243-252.